Document Preview Unavailable

Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency

Werner-Klein, Melanie; Grujovic, Ana; Irlbeck, Christoph; Obradovic, Milan; Hoffmann, Martin; et al.  bioRxiv, May 30, 2020.

You might have access to this document